Occuity
Occuity develops handheld, non-contact optical instruments that utilize light reflection analysis to measure eye health and monitor chronic conditions such as diabetes and Alzheimer's disease. Their technology enables pain-free screening in non-clinical settings, improving accessibility and reducing costs for patients and healthcare providers.
- Digital Health
- Hardware
- Healthcare Technology
- Medical Devices
Funding
Raised to date
$14.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for screening and monitoring chronic diseases like diabetes and Alzheimer's often require invasive procedures or specialized clinical settings, limiting accessibility and increasing costs. This can lead to delayed diagnosis and management of these conditions.
Solution
Occuity is developing handheld, non-contact optical instruments that use light reflection analysis to assess eye health and monitor chronic conditions. Their technology enables pain-free screening in various non-clinical environments, such as pharmacies and care homes, making it easier and more affordable to detect and manage diseases like diabetes, glaucoma, myopia, and Alzheimer's. By analyzing the light reflected from the eye, the devices can provide valuable health data, offering a non-invasive "window to the health of the body."
Target Audience
The primary target audience includes optometrists, ophthalmologists, healthcare providers in non-clinical settings (e.g., pharmacies, care homes), and individuals at risk of or affected by chronic diseases like diabetes and Alzheimer's.
Features
- Handheld, non-contact optical meters for easy and safe operation
- Patented optical technology for accurate measurement and analysis
- Devices suitable for use in both optometry/ophthalmology and general health screening
- Potential applications for screening and monitoring of glaucoma, myopia, diabetes, and Alzheimer's disease
- No consumables required, reducing operational costs